The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
Open accessAbstract
Immune mechanisms have been implicated in placental dysfunction in patients with recurrent miscarriages and intrauterine growth restriction (IUGR), but the mediators are undefined. Here we show that complement activation, particularly C5a, is a required intermediary event in the pathogenesis of placental and fetal injury in an antibody-independent mouse model of spontaneous miscarriage and IUGR, and that complement activation causes dysregulation of the angiogenic factors required for normal placental development. Pregnancies complicated by miscarriage or growth restriction were characterized by inflammatory infiltrates in placentas, functional deficiency of free vascular endothelial growth factor (VEGF), elevated levels of soluble VEGF receptor 1 (sVEGFR-1, also known as sFlt-1; a potent anti-angiogenic molecule), and defective placental development. Inhibition of complement activation in vivo blocked the increase in sVEGFR-1 and rescued pregnancies. In vitro stimulation of monocytes with products of the complement cascade directly triggered release of sVEGFR-1, which sequesters VEGF. These studies provide the first evidence linking the complement system to angiogenic factor imbalance associated with placental dysfunction, and identify a new effector of immune-triggered pregnancy complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulatory T cells mediate maternal tolerance to the fetus
Aluvihare, V. R., Kallikourdis, M., & Betz, A. G. (2004) · Nature Immunology · doi:10.1038/ni1037 · Cited by 1,657
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Fetal nutrition and adult disease
Godfrey, K. M., & Barker, D. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1344s · Cited by 1,339
Intrauterine growth restriction
Resnik, R. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01780-x · Cited by 1,022
FcR γ chain deletion results in pleiotrophic effector cell defects
Takai, T., Li, M., Sylvestre, D., Clynes, R., & Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90115-5 · Cited by 951
Maternal-Fetal Medicine: Principles and Practice
WELCH, R. A. (1985) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1985.02140060022017 · Cited by 924
Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface
Red-Horse, K., Zhou, Y., Genbacev, O., Prakobphol, A., Foulk, R., McMaster, M., & Fisher, S. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422991 · Cited by 786
Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy.
Rodesch, F., Simon, P., Donner, C., & Jauniaux, E. R. M. (1992) · PubMed · Cited by 753
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Self-citationDrusen complement components C3a and C5a promote choroidal neovascularization
Nozaki, M., Raisler, B. J., Sakurai, E., Sarma, J. V., Barnum, S. R., Lambris, J. D., Chen, Y., Zhang, K., Ambati, B. K., Baffi, J. Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408835103 · Cited by 650
Zhou, Y., McMaster, M., Woo, K., Janatpour, M., Perry, J., Karpanen, T., Alitalo, K., Damsky, C., & Fisher, S. J. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62567-9 · Cited by 640
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H., Pierangeli, S. S., Espinola, R., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 626
Self-citationThe lectin‐complement pathway – its role in innate immunity and evolution
Fujita, T., Matsushita, M., & Endo, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0123.x · Cited by 606
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 594
Self-citationComplement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 575
Self-citationA Critical Role for Murine Complement Regulator Crry in Fetomaternal Tolerance
Xu, C., Mao, D., Holers, V. M., Palanca, B., Cheng, A. M., & Molina, H. (2000) · Science · doi:10.1126/science.287.5452.498 · Cited by 524
Self-citationHLA‐G and immune tolerance in pregnancy
Hunt, J. S., Petroff, M. G., McIntire, R. H., & Ober, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2078rev · Cited by 524
A critical role for the programmed death ligand 1 in fetomaternal tolerance
Guleria, I., Khosroshahi, A., Ansari, M. J., Habicht, A., Azuma, M., Yagita, H., Noelle, R. J., Coyle, A., Mellor, A. L., Khoury, S. J., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050019 · Cited by 439
Mellor, A. L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D., & Munn, D. H. (2001) · Nature Immunology · doi:10.1038/83183 · Cited by 423
Circulating Angiogenic Factors in the Pathogenesis and Prediction of Preeclampsia
Lam, C., Lim, K.-H., & Karumanchi, S. A. (2005) · Hypertension · doi:10.1161/01.hyp.0000187899.34379.b0 · Cited by 406
Mills, J. L., Simpson, J. L., Driscoll, S. G., Jovanovic-Peterson, L., Van Allen, M., Aarons, J. H., Metzger, B., Bieber, F. R., Knopp, R. H., Holmes, L. B., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812223192501 · Cited by 402
Wang, Y., Rollins, S. A., Madri, J. A., & Matis, L. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8955 · Cited by 360
The C5a chemoattractant receptor mediates mucosal defence to infection
Höpken, U. E., Lu, B., Gerard, N. P., & Gerard, C. (1996) · Nature · doi:10.1038/383086a0 · Cited by 344
Immunology at the Maternal-Fetal Interface: Lessons for T Cell Tolerance and Suppression
Mellor, A. L., & Munn, D. H. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.367 · Cited by 286
Decay-accelerating factor modulates induction of T cell immunity
Heeger, P. S., Lalli, P. N., Lin, F., Valujskikh, A., Liu, J., Muqim, N., Xu, Y., & Medof, M. E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041967 · Cited by 286
Clark, D., Chaouat, G., Arck, P., et al. (1998) · PubMed · Cited by 279
Clark, D. A., Chaouat, G., Arck, P. C., Mittruecker, H. W., & Levy, G. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.545 · Cited by 265
Inhibition of Mannose-Binding Lectin Reduces Postischemic Myocardial Reperfusion Injury
Jordan, J. E., Montalto, M. C., & Stahl, G. L. (2001) · Circulation · doi:10.1161/hc3601.095578 · Cited by 262
How to make a placenta: Mechanisms of trophoblast cell differentiation in mice – A Review
Cross, J. C. (2005) · Placenta · doi:10.1016/j.placenta.2005.01.015 · Cited by 255
Bora, P. S., Sohn, J.-H., Cruz, J. M. C., Jha, P., Nishihori, H., Wang, Y., Kaliappan, S., Kaplan, H. J., & Bora, N. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.491 · Cited by 249
Berman, J., Girardi, G., & Salmon, J. E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.485 · Cited by 241
Self-citationHe, Y., Smith, S. K., Day, K. A., Clark, D. E., Licence, D. R., & Jones, D. S. (1999) · Molecular Endocrinology · doi:10.1210/me.13.4.537 · Cited by 226
Kim, Y. U., Kinoshita, T., Molina, H., Hourcade, D., Seya, T., Wagner, L. M., & Holers, V. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.151 · Cited by 218
Self-citationHung, T.-H., Charnock-Jones, D. S., Skepper, J. N., & Burton, G. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63192-6 · Cited by 210
Rajakumar, A., Michael, H. M., Rajakumar, P. A., Shibata, E., Hubel, C. A., Karumanchi, S. A., Thadhani, R., Wolf, M., Harger, G., & Markovic, N. (2005) · Placenta · doi:10.1016/j.placenta.2004.09.001 · Cited by 190
Tumor Necrosis Factors: Pivotal Components of Pregnancy?1
Hunt, J. S., Chen, H.-L., & Miller, L. (1996) · Biology of Reproduction · doi:10.1095/biolreprod54.3.554 · Cited by 174
Patterson, C., Perrella, M. A., Endege, W. O., Yoshizumi, M., Lee, M. E., & Haber, E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118816 · Cited by 169
Thurman, J. M., Kraus, D. M., Girardi, G., Hourcade, D., Kang, H. J., Royer, P. A., Mitchell, L. M., Giclas, P. C., Salmon, J., Gilkeson, G., et al. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.043 · Cited by 162
Self-citationBandt, M. D., Mahdi, M. H. B., Ollivier, V., Grossin, M., Dupuis, M., Gaudry, M., Böhlen, P., Lipson, K. E., Rice, A. G., Wu, Y. L., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4853 · Cited by 125
Requirement of the mouse I‐mfa gene for placental development and skeletal patterning
Kraut, N., Snider, L. D., Chen, C.-M. A., Tapscott, S. J., & Groudine, M. T. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6276 · Cited by 111
Strachan, A. J., Woodruff, T. M., Haaima, G., Fairlie, D. P., & Taylor, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6560 · Cited by 102
Blois, S. M., Tometten, M., Kandil, J., Hagen, E., Klapp, B. F., Margni, R. A., & Arck, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1820 · Cited by 102
The Role of Placental Trophoblast in the Pathophysiology of the Antiphospholipid Antibody Syndrome
Rote, N. S., Vogt, E., Devere, G., Obringer, A. R., & Ng, A. (1998) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1998.tb00344.x · Cited by 98
Eubank, T. D., Roberts, R. D., Galloway, M., Wang, Y., Cohn, D. E., & Marsh, C. B. (2004) · Immunity · doi:10.1016/j.immuni.2004.10.011 · Cited by 98
Placental vascular morphogenesis
Jones, D. S., & Burton, G. J. (2000) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2000.0137 · Cited by 96
Mao, D., Wu, X., Deppong, C. M., Friend, L. D., Dolecki, G. J., Nelson, D. M., & Molina, H. D. (2003) · Immunity · doi:10.1016/s1074-7613(03)00321-2 · Cited by 94
Soluble Receptors Neutralizing TNF‐α and IL‐1 Block Stress‐Triggered Murine Abortion
Arck, P., CLARK, D. A., & Troutt, A. B. (1997) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1997.tb00225.x · Cited by 93
Carroll, M. C., & Holers, V. M. (2005) · Advances in immunology · doi:10.1016/s0065-2776(04)86004-8 · Cited by 93
Self-citationAt the Innate Frontiers between Mother and Fetus
Caucheteux, S. M., Kanellopoulos‐Langevin, C., & Ojcius, D. M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00028-1 · Cited by 73
Higginbottom, A., Cain, S. A., Woodruff, T. M., Proctor, L. M., Madala, P. K., Tyndall, J. D. A., Taylor, S. M., Fairlie, D. P., & Monk, P. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410797200 · Cited by 54
Cited by
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,191
Pre-eclampsia part 1: current understanding of its pathophysiology
Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., & Romero, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.102 · Cited by 956
Silica and titanium dioxide nanoparticles cause pregnancy complications in mice
Yamashita, K., Yoshioka, Y., Higashisaka, K., Mimura, K., Morishita, Y., Nozaki, M., Yoshida, T., Ogura, T., Nabeshi, H., Nagano, K., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.41 · Cited by 738
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.52 · Cited by 620
Complement and Its Receptors: New Insights into Human Disease
Holers, V. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120154 · Cited by 430
Self-citation
Metadata
- Authors
- Girardi, G., Yarilin, D., Thurman, J. M., Holers, V. M., & Salmon, J. E.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-08-21
- Volume
- 203
- Issue
- 9
- Pages
- 2165-2175
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2140537006
- Cited by
- 508
- References
- 55
- FWCI
- 30.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.